Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 74 of 74 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/06
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/09
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 01/31/08
Due: 01/31/09
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 05/31/10
Due: 05/31/11
Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia
Phase: N/A
Priority: Normal
Start: 03/31/05
End: 07/31/12
Due: 07/31/13
Phase: N/A
Priority: Normal
Start: 02/28/11
End: 05/31/12
Due: 05/31/13
Phase: N/A
Priority: Normal
Start: 05/19/21
End: 10/01/22
Due: 10/01/23
Phase: N/A
Priority: Normal
Start: 05/31/11
End: 06/30/13
Due: 06/30/14
Phase: N/A
Priority: Normal
Start: 10/18/23
End: 01/01/26
Due: 01/01/27
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 02/29/08
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 02/06/24
End: 12/31/26
Due: 12/31/27
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 04/30/15
Due: 04/30/16
Phase: N/A
Priority: Normal
Start: 01/31/15
End: 05/31/16
Due: 05/31/17
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 01/31/30
Due: 01/31/31
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 12/31/06
Due: 12/31/07
Phase: N/A
Priority: Normal
Start: 01/31/13
End: 05/31/20
Due: 05/31/21
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 08/31/10
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: 06/30/08
End: 03/31/09
Due: 03/31/10
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 03/31/13
Due: 03/31/14
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 12/31/12
Due: 12/31/13